Underdog Pharmaceuticals Company
Underdog develops interventions targeting toxic forms of cholesterol to provide true disease-modifying treatments for age-related diseases.
Industry:
Pharmaceutical
Last Funding Date:
2019
Investors Number:
4
Last Funding Type:
Seed
Headquarters:
Mountain View, California, United States
Founded Date:
2019
Funding Status:
Seed
Total Funding:
4000000
Employee Number:
1-10